# Current challenges in allergic diseases and computational solutions towards personalized medicine

## TL;DR

Allergic diseases are becoming more common globally, and this paper discusses how computational tools can help improve personalized treatment strategies.

## Contribution

The paper highlights the use of statistical computational tools for predicting allergenicity to advance precision medicine in allergic diseases.

## Key findings

- Allergic diseases affect 10% to 30% of the global population, with rising prevalence due to urbanization and climate change.
- Diagnostic limitations and clinical heterogeneity pose major challenges in managing allergic diseases.
- Computational methods offer new opportunities for precision medicine in allergy treatment.

## Abstract

Allergic diseases persist as a significant global health concern, profoundly diminishing the quality of life for millions of people across the globe. Allergic diseases exert a growing economic toll worldwide, with prevalence rates rising sharply – now affecting between 10% and 30% of the global population. This upward trend underscores the urgent need for more effective prevention, diagnosis, and management strategies. Rapid urbanization and shifting environmental conditions – particularly those driven by global warming – are increasingly recognized as key contributors to the rising prevalence of allergic diseases worldwide. We examine the current challenges in addressing these complex disorders, from diagnostic limitations to the heterogeneity of clinical presentations. We explore the role of statistical computational tools in predicting allergenicity, offering new avenues for precision medicine in this evolving field.